Murph
:)
- Messages
- 1,799
Brain Behav Immun. 2019 Jun 6. pii: S0889-1591(19)30208-9. doi: 10.1016/j.bbi.2019.06.010. [Epub ahead of print]
Patients with fibromyalgia and chronic fatigue syndrome show increased hsCRP compared to healthy controls.
Groven N1, Fors EA2, Klæbo Reitan S3.
Author information
Abstract
Chronic Fatigue Syndrome (CFS) and Fibromyalgia (FM) are both chronic disorders that have a devastating effect on the lives of the affected patients and their families. Both conditions have overlapping clinical features that partly resemble those of inflammatory disorders. The etiology is still not understood, and it is suggested that the immune system might be a contributing factor. So far, the results are inconclusive.
The purpose of this study was to compare the two conditions and investigate the level of the inflammatory marker high-sensitivity CRP (hsCRP) in CFS and FM patients compared to healthy controls. Female participants aged 18-60 years were enrolled in this study. The group consisted of 49 CFS patients, 57 FM patients, and 54 healthy controls. hsCRP levels were significantly higher for both the CFS and the FM groups compared to healthy controls when adjusting for age, smoking, and BMI (p < .001).
There was no difference between the two patient groups. The level of hsCRP was affected by BMI but not by age and smoking. Patients with CFS and FM have higher concentrations of hsCRP compared to healthy controls. This remains significant even after adjusting for BMI. CFS and FM cannot be distinguished from each other on the basis of hsCRP in our study.
Copyright © 2019. Published by Elsevier Inc.
KEYWORDS:
BMI; Body-Mass Index; C-reactive protein; CFS; CRP; Chronic Fatigue Syndrome; FM; Fibromyalgia; Inflammation; hsCRP
PMID: 31176728 DOI: 10.1016/j.bbi.2019.06.010
Patients with fibromyalgia and chronic fatigue syndrome show increased hsCRP compared to healthy controls.
Groven N1, Fors EA2, Klæbo Reitan S3.
Author information
Abstract
Chronic Fatigue Syndrome (CFS) and Fibromyalgia (FM) are both chronic disorders that have a devastating effect on the lives of the affected patients and their families. Both conditions have overlapping clinical features that partly resemble those of inflammatory disorders. The etiology is still not understood, and it is suggested that the immune system might be a contributing factor. So far, the results are inconclusive.
The purpose of this study was to compare the two conditions and investigate the level of the inflammatory marker high-sensitivity CRP (hsCRP) in CFS and FM patients compared to healthy controls. Female participants aged 18-60 years were enrolled in this study. The group consisted of 49 CFS patients, 57 FM patients, and 54 healthy controls. hsCRP levels were significantly higher for both the CFS and the FM groups compared to healthy controls when adjusting for age, smoking, and BMI (p < .001).
There was no difference between the two patient groups. The level of hsCRP was affected by BMI but not by age and smoking. Patients with CFS and FM have higher concentrations of hsCRP compared to healthy controls. This remains significant even after adjusting for BMI. CFS and FM cannot be distinguished from each other on the basis of hsCRP in our study.
Copyright © 2019. Published by Elsevier Inc.
KEYWORDS:
BMI; Body-Mass Index; C-reactive protein; CFS; CRP; Chronic Fatigue Syndrome; FM; Fibromyalgia; Inflammation; hsCRP
PMID: 31176728 DOI: 10.1016/j.bbi.2019.06.010